NHAS

Novo Holdings A/S Portfolio holdings

AUM $1.55B
1-Year Est. Return 16.8%
This Quarter Est. Return
1 Year Est. Return
+16.8%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.93B
AUM Growth
-$321M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
57
New
Increased
Reduced
Closed

Top Buys

1
+$150M
2
+$16M
3
+$5.46M
4
FOLD icon
Amicus Therapeutics
FOLD
+$5.37M
5
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
+$4.57M

Top Sells

1
+$53M
2
+$43.1M
3
+$33.7M
4
INZY
Inozyme Pharma
INZY
+$31.8M
5
PTGX icon
Protagonist Therapeutics
PTGX
+$26.9M

Sector Composition

1 Healthcare 57.28%
2 Financials 8.56%
3 Technology 7.59%
4 Consumer Discretionary 1.65%
5 Communication Services 1.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
– –
-1,867,706
52
– –
-279,676
53
– –
-600,010
54
– –
-31,769
55
– –
-11,854
56
– –
-508,922
57
– –
-53,300
1 2
3